CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Differential MicroRNA Expression between EGFR T790M and L858R Mutated Lung Cancer
Ji Yeon Kim, Woo Jeong Lee, Ha Young Park, Ahrong Kim, Dong Hoon Shin, Chang Hun Lee
JPTM. 2018;52(5):275-282.   Published online 2018 August 16    DOI: https://doi.org/10.4132/jptm.2018.07.29

Excel Download

Differential MicroRNA Expression between EGFR T790M and L858R Mutated Lung Cancer
Journal of Pathology and Translational Medicine. 2018;52(5):275-282   Crossref logo
Link1 Link2 Link3

EGFR L718V (+)/T790M (–) as a Mechanism of Resistance in Patients with Metastatic Non–small-cell Lung Cancer with EGFR L858R Mutations
Clinical Lung Cancer. 2021;22(6):e817-e819   Crossref logo
Link1 Link2

Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3 -mutation, localized transformation to EGFR -mutated SCLC, and acquired T790M EGFR -mutation
Lung Cancer. 2017;113:14-17   Crossref logo
Link1 Link2

Utility of T790M plasma and tissue biopsy testing in EGFR mutated non-small-cell lung cancer patients
Lung Cancer. 2020;139:S61-S62   Crossref logo
Link1 Link2

Durable response to osimertinib in EGFR mutated T790M wildtype non-small cell lung cancer with leptomeningeal metastases: A case report
Lung Cancer. 2017;114:68-69   Crossref logo
Link1 Link2

Unusual metachronous lung adenocarcinomas harboring EGFR L858R / T790M mutations: A case report
Thoracic Cancer. 2020;11(10):3020-3023   Crossref logo
Link1 Link2 Link3

AI-Based Drug Discovery of TKIs Targeting L858R/T790M/C797S-Mutant EGFR in Non-small Cell Lung Cancer
Frontiers in Pharmacology. 2021;12:   Crossref logo
Link1

71: Early experience with osimertinib as second line treatment for EGFR mutated non-small cell lung cancer (NSCLC) and detecting T790M mutations from plasma circulating tumour DNA (ctDNA)
Lung Cancer. 2017;103:S34   Crossref logo
Link1 Link2

Impact of coexisting gene mutations in EGFR-mutated non–small cell lung cancer before treatment on EGFR T790M mutation status after EGFR-TKIs
Lung Cancer. 2020;139:28-34   Crossref logo
Link1 Link2

Osimertinib With Ramucirumab in EGFR-mutated, T790M-positive Patients With Progression During EGFR-TKI Therapy: Phase Ib Study
Clinical Lung Cancer. 2018;19(6):e871-e874   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. J Pathol Transl Med has participated in CrossRef Text and Data Mining service since January 16, 2015.